Market Tracker

05/24 5:16pm ET

Novartis AG (NYSE:NVS)

78.42
Delayed Data
As of 4:02pm ET
 +0.29 / +0.37%
Today’s Change
69.90
Today|||52-Week Range
106.84
-8.86%
Year-to-Date
Novartis Filing for MabThera Biosimilar Accepted in the EU
6:04pm / Zacks.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Ophthotech
May 17 / MotleyFool.com - Paid Partner Content
The Best Buys in Biopharma Today
9:12am / MotleyFool.com - Paid Partner Content
Novartis (NVS) Releases Positive Data on Ultibro Breezhaler
May 16 / Zacks.com - Paid Partner Content
Novartis' Cardiovascular Drug Gets Positive Recommendation
May 23 / Zacks.com - Paid Partner Content
Drug Stocks Reporting Earnings on May 17: AXON & FWP
May 16 / Zacks.com - Paid Partner Content
Will These Game-Changing Cancer Treatments Hit the Market in 2016?
May 19 / MotleyFool.com - Paid Partner Content
Drug Stocks' Earnings Slated for This Week: RDY, AVXS, ESALY
May 11 / Zacks.com - Paid Partner Content
Novartis (NVS) to Stop Trial on Breast Cancer Drug Early
May 18 / Zacks.com - Paid Partner Content
The Medicines Co. Loss Wider, to Divest Cardiovascular Drugs
May 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close78.13
Today’s open77.95
Day’s range77.91 - 78.70
Volume1,729,204
Average volume (3 months)2,402,206
Market cap$181.6B
Dividend yield3.47%
Data as of 4:02pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+77.51%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.04%
Revenue growth (last year)-4.75%
P/E ratio27.9
Price/Sales4.25
Price/Book2.41

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc+9.31+1.14%
PFEPfizer+0.43+1.28%
MRKMerck+0.68+1.24%
BMYBristol-Myers Squibb+0.83+1.18%
Data as of 4:02pm ET, 05/24/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$1.21
Annual revenue (last year)$49.4B
Annual profit (last year)$17.8B
Net profit margin14.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts